Journal article icon

Journal article

Improving Care in Eosinophil-Associated Diseases: A Charter

Abstract:
Eosinophil-associated diseases (EADs) are a range of heterogeneous conditions in which eosinophils are believed to play a critical pathological role. EADs include common illnesses such as eosinophilic asthma and chronic rhinosinusitis and rare conditions such as hypereosinophilic syndromes (HES) and eosinophilic gastrointestinal disorders (EGIDs). EADs are associated with substantial burdens for the patient, including chronic, debilitating symptoms, increased financial burden, decreased health-related quality of life, and the need for repeated visits to multiple different healthcare professionals (HCPs), emergency departments, and/or hospitals. Poor EAD recognition by HCPs often contributes to delayed diagnoses, which further delays patient access to appropriate care and effective treatments, contributing to poor health outcomes. The objective of this charter is to outline key patient rights and expectations with respect to the management of their condition(s) and to set forth an ambitious action plan to improve health outcomes for patients with EADs: (1) people with EADs, their caretakers, HCPs, and the public must have greater awareness and education about EADs; (2) people with EADs must receive a timely, accurate diagnosis; (3) all people with EADs must have access to an appropriate multidisciplinary team, when necessary; and (4) people with EADs must have access to safe and effective treatment options without unnecessary regulatory delays. The principles described in this charter demonstrate the core elements of quality care that people with EADs must receive, and they represent clear steps by which to reduce patient and caregiver burden and improve patient outcomes. We urge HCPs, healthcare systems, and policymakers worldwide to swiftly adopt these principles to ensure patients with EADs have an accurate diagnosis in a timely manner and access to high-level care and treatment in an appropriate setting.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s12325-022-02110-8

Authors

More by this author
Role:
Author
ORCID:
0000-0002-2299-868X
More by this author
Role:
Author
ORCID:
0000-0001-6655-7520
More by this author
Role:
Author
ORCID:
0000-0001-5918-2062


More from this funder
Funder identifier:
10.13039/100004325


Publisher:
Springer
Journal:
Advances in Therapy More from this journal
Volume:
39
Issue:
6
Pages:
2323-2341
Publication date:
2022-04-30
DOI:
EISSN:
1865-8652
ISSN:
0741-238X


Language:
English
Keywords:
Pubs id:
1259627
Local pid:
pubs:1259627
Source identifiers:
W4225164649
Deposit date:
2026-04-24
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP